OtherState-of-the-Art (Invitation Only)
Open Access
68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha and Shaojun Zhu
Journal of Nuclear Medicine December 2020, jnumed.120.260455; DOI: https://doi.org/10.2967/jnumed.120.260455
Giuseppe Carlucci
1 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, United States;
Robin Ippisch
2 Department of Radiology and Biomedical Imaging, University of California, San Francisco, United States;
Roger Slavik
1 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, United States;
Ashley Mishoe
3 Department of Radiology and Biomedical Imaging, University of California, San Francisco,, United States
Joseph Blecha
2 Department of Radiology and Biomedical Imaging, University of California, San Francisco, United States;
Shaojun Zhu
1 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, United States;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha, Shaojun Zhu
Journal of Nuclear Medicine Dec 2020, jnumed.120.260455; DOI: 10.2967/jnumed.120.260455
Jump to section
Related Articles
Cited By...
- One Hundred Years of the Tracer Principle
- Designed Ankyrin Repeat Proteins for detecting prostate-specific antigen expression in vivo
- SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer--Use of Imaging Agents in Therapeutic Drug Development and Approval
- Tailored Media-Fill Test Protocols Inspired by 68Ga Kit-Based Radiopharmaceuticals
- An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients